Skip to content
The Policy VaultThe Policy Vault

sorafenib — Medica

Bone cancer

Initial criteria

  • age ≥ 18 years
  • EITHER recurrent chordoma OR osteosarcoma AND tried one systemic chemotherapy regimen (e.g., cisplatin, doxorubicin, methotrexate, or ifosfamide)

Approval duration

1 year